SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029577
Filing Date
2018-11-14
Accepted
2018-11-14 16:16:56
Documents
82
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-10q_20180930.htm 10-Q 2313381
2 EX-31.1 isco-ex311_7.htm EX-31.1 9329
3 EX-31.2 isco-ex312_6.htm EX-31.2 9339
4 EX-32.1 isco-ex321_8.htm EX-32.1 6056
5 EX-32.2 isco-ex322_10.htm EX-32.2 6244
  Complete submission text file 0001564590-18-029577.txt   10593173

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isco-20180930.xml EX-101.INS 2761878
7 XBRL TAXONOMY EXTENSION SCHEMA isco-20180930.xsd EX-101.SCH 71875
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20180930_cal.xml EX-101.CAL 43183
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20180930_def.xml EX-101.DEF 332212
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20180930_lab.xml EX-101.LAB 500283
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20180930_pre.xml EX-101.PRE 471359
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 181184006
SIC: 2834 Pharmaceutical Preparations